MASH and MASLD are prevalent, complex diseases often accompanied by metabolic comorbidities like obesity and diabetes. GLP-1 receptor agonists, such as semaglutide, show promise in resolving NASH ...

Souza M, Al-Sharif L, Diaz I, et al. Representation of sex, race and ethnicity in mash randomised controlled trials: a systematic review and meta-analysis. Liver Int . 2025;45(4):e70029. doi:10. ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...

Truong Minh Quy’s haunting romance between two Vietnamese coal miners contemplates war and loss with pained elegance. By Lisa Kennedy Louise Courvoisier’s debut feature follows a teenager in ...